Analysis showed dose- and time-dependent effects on toxicological endpoints in astrocytoma cells, where higher doses gave reduced viability, changes in expression of apoptotic proteins, reduced expression of APP, and increased intercellular communication. The gene discussed is APP; the disease is astrocytoma (excluding glioblastoma).